ClinicalTrials.Veeva

Menu

Direct Oral Anticoagulants and Management of Blleding Following Dental Extractions. A Prospective Cohort Study. (DOACS_1)

U

University of Pisa

Status

Completed

Conditions

Post Operative Hemorrhage

Study type

Observational

Funder types

Other

Identifiers

NCT06365242
DOACS1_2024

Details and patient eligibility

About

Evaluation of DOACs treatment on post-extraction bleeding

Full description

Consecutive patients requiring at least one dental extraction were enrolled. DOACs regimen was either maintained or suspended. Patients were classified in subgroups depending on the number of teeth extracted per procedure (≤ 3 or > 3), the need for flap raising and the performance of osteotomy. Bleeding was recorded intraoperatively, perioperatively at 20, 40, 60 and 80 minutes after the procedure, and in the first seven days post-operatively.

Enrollment

49 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age >18 years
  • patients under pharmacological treatment with DOACs
  • patients requiring at least one dental extraction
  • patients willing to take part in the study and to sign informed consent

Exclusion criteria

  • patients below 18 years of age
  • patients treated with antiplatelet therapy or vitamin K antagonists
  • patients presenting with an International Normalized Ratio (INR) >3.0
  • patients suffering from congenital or acquired coagulopathies (e.g. haemophilia, coagulation factors deficiency, von Willebrand disease, thrombocytopenia, cirrhosis)

Trial design

49 participants in 1 patient group

DOACs treated patients
Description:
Patients treated with DOACs undergoing oral extractions

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems